Beneficial effects of the combination of BCc1 and Hep-S nanochelating-based medicines on IL-6 in hospitalized moderate COVID-19 adult patients: a randomized, double-blind, placebo-controlled clinical trial
Article in Trials (November 2023)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in Trials (November 2023)
Article in Viral Immunology (July 2023)
Preprint in SSRN Electronic Journal (January 2022)